PCN54 ESTIMATING THE CLINICAL BENEFITS OF HPV-16/18 VACCINATION- CHALLENGES OF MODELING PREDICTED CASES OF CERVICAL CANCER IN POLAND AND MEXICO, TWO COUNTRIES WITH DIFFERING DEGREES OF CERVICAL DISEASE AND POPULATION STABILITY
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63484-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)63484-5/fulltext
Title :
PCN54 ESTIMATING THE CLINICAL BENEFITS OF HPV-16/18 VACCINATION- CHALLENGES OF MODELING PREDICTED CASES OF CERVICAL CANCER IN POLAND AND MEXICO, TWO COUNTRIES WITH DIFFERING DEGREES OF CERVICAL DISEASE AND POPULATION STABILITY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63484-5&doi=10.1016/S1098-3015(10)63484-5
First page :
Section Title :
Open access? :
No
Section Order :
336